Asset Management - Income
Compare Stocks
2 / 10Stock Comparison
NXC vs TROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
NXC vs TROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management - Income | Asset Management |
| Market Cap | $86M | $22.54B |
| Revenue (TTM) | $4M | $7.31B |
| Net Income (TTM) | $7M | $2.09B |
| Gross Margin | 100.0% | 62.7% |
| Operating Margin | 90.8% | 29.9% |
| Forward P/E | 38.0x | 11.2x |
| Total Debt | $6K | $860M |
| Cash & Equiv. | $391K | $3.38B |
NXC vs TROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Jan 26 | Return |
|---|---|---|---|
| Nuveen California S… (NXC) | 100 | 85.8 | -14.2% |
| T. Rowe Price Group… (TROW) | 100 | 84.7 | -15.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NXC vs TROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NXC is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.04
- Lower volatility, beta 0.04, Low D/E 0.0%, current ratio 4.13x
- Beta 0.04, current ratio 4.13x
TROW carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.1%, EPS growth 1.1%
- 93.6% 10Y total return vs NXC's 13.1%
- 3.1% NII/revenue growth vs NXC's -28.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% NII/revenue growth vs NXC's -28.6% | |
| Value | Lower P/E (11.2x vs 38.0x) | |
| Quality / Margins | Efficiency ratio 0.1% vs TROW's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.04 vs TROW's 1.18, lower leverage | |
| Dividends | 4.9% yield; 3-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +18.9% vs NXC's +4.2% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs TROW's 0.3% |
NXC vs TROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NXC vs TROW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NXC leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
TROW is the larger business by revenue, generating $7.3B annually — 1974.9x NXC's $4M. NXC is the more profitable business, keeping 60.7% of every revenue dollar as net income compared to TROW's 28.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $4M | $7.3B |
| EBITDAEarnings before interest/tax | $7M | $2.7B |
| Net IncomeAfter-tax profit | $7M | $2.1B |
| Free Cash FlowCash after capex | $0 | $2.3B |
| Gross MarginGross profit ÷ Revenue | +100.0% | +62.7% |
| Operating MarginEBIT ÷ Revenue | +90.8% | +29.9% |
| Net MarginNet income ÷ Revenue | +60.7% | +28.5% |
| FCF MarginFCF ÷ Revenue | — | +20.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -88.4% | +3.7% |
Valuation Metrics
TROW leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
At 11.2x trailing earnings, TROW trades at a 71% valuation discount to NXC's 38.0x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $86M | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $85M | $20.0B |
| Trailing P/EPrice ÷ TTM EPS | 37.97x | 11.20x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.64x |
| Price / SalesMarket cap ÷ Revenue | 23.16x | 3.08x |
| Price / BookPrice ÷ Book value/share | 0.96x | 1.92x |
| Price / FCFMarket cap ÷ FCF | — | 15.24x |
Profitability & Efficiency
TROW leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
TROW delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $8 for NXC. NXC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROW's 0.07x. On the Piotroski fundamental quality scale (0–9), TROW scores 4/9 vs NXC's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.3% | +17.6% |
| ROA (TTM)Return on assets | +8.3% | +14.4% |
| ROICReturn on invested capital | +2.8% | +13.3% |
| ROCEReturn on capital employed | +3.8% | +15.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 0.07x |
| Net DebtTotal debt minus cash | -$390,878 | -$2.5B |
| Cash & Equiv.Liquid assets | $390,878 | $3.4B |
| Total DebtShort + long-term debt | $6,477 | $860M |
| Interest CoverageEBIT ÷ Interest expense | 85.16x | — |
Total Returns (Dividends Reinvested)
TROW leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NXC five years ago would be worth $9,665 today (with dividends reinvested), compared to $6,915 for TROW. Over the past 12 months, TROW leads with a +18.9% total return vs NXC's +4.2%. The 3-year compound annual growth rate (CAGR) favors TROW at 3.7% vs NXC's 3.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.2% | +0.2% |
| 1-Year ReturnPast 12 months | +4.2% | +18.9% |
| 3-Year ReturnCumulative with dividends | +9.7% | +11.5% |
| 5-Year ReturnCumulative with dividends | -3.4% | -30.9% |
| 10-Year ReturnCumulative with dividends | +13.1% | +93.6% |
| CAGR (3Y)Annualised 3-year return | +3.1% | +3.7% |
Risk & Volatility
NXC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NXC is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than TROW's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXC currently trades 98.8% from its 52-week high vs TROW's 87.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.07x | 1.16x |
| 52-Week HighHighest price in past year | $13.45 | $118.22 |
| 52-Week LowLowest price in past year | $12.66 | $85.51 |
| % of 52W HighCurrent price vs 52-week peak | +98.8% | +87.6% |
| RSI (14)Momentum oscillator 0–100 | 60.1 | 78.2 |
| Avg Volume (50D)Average daily shares traded | 0 | 2.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
TROW is the only dividend payer here at 4.93% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $101.20 |
| # AnalystsCovering analysts | — | 38 |
| Dividend YieldAnnual dividend ÷ price | — | +4.9% |
| Dividend StreakConsecutive years of raises | — | 3 |
| Dividend / ShareAnnual DPS | — | $5.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.8% |
TROW leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). NXC leads in 2 (Income & Cash Flow, Risk & Volatility).
NXC vs TROW: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is NXC or TROW a better buy right now?
For growth investors, T.
Rowe Price Group, Inc. (TROW) is the stronger pick with 3. 1% revenue growth year-over-year, versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 2x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate T. Rowe Price Group, Inc. (TROW) a "Hold" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NXC or TROW?
On trailing P/E, T.
Rowe Price Group, Inc. (TROW) is the cheapest at 11. 2x versus Nuveen California Select Tax-Free Income Portfolio at 38. 0x.
03Which is the better long-term investment — NXC or TROW?
Over the past 5 years, Nuveen California Select Tax-Free Income Portfolio (NXC) delivered a total return of -3.
4%, compared to -30. 9% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: TROW returned +95. 9% versus NXC's +13. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NXC or TROW?
By beta (market sensitivity over 5 years), Nuveen California Select Tax-Free Income Portfolio (NXC) is the lower-risk stock at 0.
07β versus T. Rowe Price Group, Inc. 's 1. 16β — meaning TROW is approximately 1667% more volatile than NXC relative to the S&P 500. On balance sheet safety, Nuveen California Select Tax-Free Income Portfolio (NXC) carries a lower debt/equity ratio of 0% versus 7% for T. Rowe Price Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NXC or TROW?
By revenue growth (latest reported year), T.
Rowe Price Group, Inc. (TROW) is pulling ahead at 3. 1% versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). On earnings-per-share growth, the picture is similar: T. Rowe Price Group, Inc. grew EPS 1. 1% year-over-year, compared to -56. 3% for Nuveen California Select Tax-Free Income Portfolio. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NXC or TROW?
Nuveen California Select Tax-Free Income Portfolio (NXC) is the more profitable company, earning 60.
7% net margin versus 28. 5% for T. Rowe Price Group, Inc. — meaning it keeps 60. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXC leads at 90. 8% versus 29. 9% for TROW. At the gross margin level — before operating expenses — NXC leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — NXC or TROW?
In this comparison, TROW (4.
9% yield) pays a dividend. NXC does not pay a meaningful dividend and should not be held primarily for income.
08Is NXC or TROW better for a retirement portfolio?
For long-horizon retirement investors, Nuveen California Select Tax-Free Income Portfolio (NXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
07)). Both have compounded well over 10 years (NXC: +13. 1%, TROW: +95. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NXC and TROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NXC is a small-cap quality compounder stock; TROW is a mid-cap deep-value stock. TROW pays a dividend while NXC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare TROW vs BEN
BEN is one of the most direct listed alternatives to TROW.
Compare NXC vs BLK
Compare NXC against another closely matched public peer instead of a generic same-sector name.
Expand With BEN + IVZ
BEN and IVZ are the strongest missing peers across the current compare set.